BABA [Alibaba] 13F-HR: (Original Filing)

[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;} .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;} .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, s]

By | 2019-02-15T04:36:03+00:00 February 14th, 2019|Categories: BABA, Chinese Stocks, Ownership, SEC Original|Tags: , , , , , |0 Comments

WB [WEIBO] SC 13G/A: (Original Filing)

[Harding Loevner LP I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) 27-068-4167 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 2,26]

CO [Global Cord Blood] SC 13G/A: SCHEDULE 13G/A Amendment No. 14 Global Cord Blood

[SCHEDULE 13G/A Amendment No. 14 Global Cord Blood Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 698659109 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) *]

By | 2019-02-14T13:05:04+00:00 February 14th, 2019|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

KANG [iKang Healthcare] SC 13G/A: SCHEDULE 13G (Amendment No. __3______)* iKang Healthcare Group,

[SCHEDULE 13G (Amendment No. __3______)* iKang Healthcare Group, Inc. (Name of Issuer) Class A common shares, par value US$0.01 per share, including in the form of American Depositary Shares (each representing 1/2 of a Class A common share) (Title of Class of Securities) 45174L108 (CUSIP Number) Dece]

BABA [Alibaba] 13F-HR: .FormData {color: blue; background-color: white; font-size: small; font-family:

[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;} .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;} .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, s]

By | 2019-02-15T04:36:07+00:00 February 14th, 2019|Categories: BABA, Chinese Stocks, Ownership, Webplus ver|Tags: , , , , , |0 Comments

WB [WEIBO] SC 13G/A: Harding Loevner LP I.R.S. IDENTIFICATION NO. OF ABOVE

[Harding Loevner LP I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) 27-068-4167 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 2,26]

CBPO [China Biologic Products] SC 13G/A: (Original Filing)

[1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Capital Research Global Investors ** 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware 5 SOLE VOTING POWER 2,087,348 6 S]

HGSH [CHINA HGS REAL ESTATE] 8-K: (Original Filing)

[China HGS Reports First Quarter of Fiscal Year 2019 Results HANZHONG, CHINA February 14 2019 www.sec.gov Highlights for the quarter l Total revenues for the first quarter of fiscal 2019 were approximately $7.7 million, a decrease of 46.4% from approximately $14.4 million in the same quarter of fisca]

By | 2019-02-14T13:02:41+00:00 February 14th, 2019|Categories: Chinese Stocks, HGSH, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar